PharmaShots Weekly Snapshot (October 21-25, 2019)

1. Urology San Antonio Collaborates with Anixa Biosciences on Ccheck Prostate Cancer Study

Published: Oct 25, 2019 | Tags: Urology San Antonio, Collaborates, Anixa Biosciences, Ccheck, Prostate Cancer Study

2. NHS England Signs an Agreement with Vertex to Access All Licensed Cystic Fibrosis Therapies

Published: Oct 24, 2019 | Tags: NHS England, Signs, Agreement, Vertex, Access, Licensed, Cystic Fibrosis Therapies

3. Zentiva to Acquire Alvogen’s Generics and OTC Business in Central and Eastern Europe

Published: Oct 25, 2019 | Tags: Zentiva, Acquire, Alvogen, Generics, OTC, Business, Central and Eastern Europe

 4. Astellas’ Xospata (gilteritinib) Receives EC’s Approval as Monotherapy for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation

Published: Oct 25, 2019 | Tags: Astellas, Xospata, gilteritinib, Receives, EC, Approval, Monotherapy, Relapsed, Refractory, Acute Myeloid Leukemia, FLT3 Mutation

5. Allergan’s BOTOX (onabotulinumtoxinA) Receives the US FDA’s Approval for Pediatric Patients with Lower Limb Spasticity Excluding Spasticity Caused by Cerebral Palsy

Published: Oct 24, 2019 | Tags: Allergan, BOTOX, onabotulinumtoxinA, Receives, US, FDA, Approval, Pediatric Patients, Lower Limb Spasticity, Spasticity Caused by Cerebral Palsy

6. AbbVie Collaborate with Cystic Fibrosis Foundation to Advance CFTR Potentiator

Published: Oct 24, 2019 | Tags: AbbVie, Collaborate, Cystic Fibrosis Foundation, Advance, CFTR Potentiator

7. NovoCodex Collaborates with Ambrx to Develop and Commercialize its ARX305 in China

Published: Oct 23, 2019 | Tags: NovoCodex, Collaborates, Ambrx, Develop, Commercialize, ARX305, China

8. WHO Signs MoU with IGBA for Promoting the Access to Biosimilars and Generics

Published:  Oct 23, 2019 | Tags: WHO, Signs, MoU, IGBA, Promote, Access, Biosimilars, Generics

9. Bausch Health In-Licenses Clearside’s Xipere (triamcinolone acetonide suprachoroidal injectable suspension) For Macular Edema Associated with Uveitis

Published: Oct 24, 2019 | Tags: Bausch Health, In-Licenses, Clearside, Xipere, triamcinolone acetonide suprachoroidal injectable suspension, Macular Edema Associated with Uveitis

10. GSK’s Zejula (niraparib) Receives FDA’s Approval for Late-line Treatment in Women with Recurrent Ovarian Cancer

Published: Oct 23, 2019 | Tags: GSK, Zejula, niraparib, Receives, FDA, Approval, Late-line Treatment, Women, Recurrent Ovarian Cancer

11. Novartis Collaborates with Pliant Therapeutics to Develop Therapies for NASH and Fibrotic Diseases

Published: Oct 24, 2019 | Tags: Novartis, Collaborates, Pliant Therapeutics, Develop, Therapies, NASH, Fibrotic Diseases

12. Biomica Signs an Agreement with Weizmann Institute of Science to Develop a Selective Treatment Against Antibiotic-Resistant Bacteria

Published: Oct 23, 2019 | Tags: Biomica, Signs, Agreement, Weizmann Institute of Science, Develop, Selective, Treatment, Against, Antibiotic Resistant Bacteria

13. Brii Biosciences Collaborates with Qpex to Develop and Commercialize Antibiotics for Drug-Resistant Infections in China

Published: Oct 22, 2019 | Tags: Brii Biosciences, Collaborates, Qpex, Develop, Commercialize, Antibiotics, Drug-Resistant Infections, China

14. BerGenBio’s Bemcentinib Receives the US FDA’s Fast Track Designation for Relapsed Acute Myeloid Leukemia

Published: Oct 22, 2019 | Tags: BerGenBio, Bemcentinib, Receives, US, FDA, Fast Track Designation, Relapsed Acute Myeloid Leukemia

15. Biogen and Eisai Plan to File BLA to the US FDA for Aducanumab to Treat Alzheimer’s Disease

Published: Oct 22, 2019 | Tags: Biogen, Eisai, Plan, File, BLA, US, FDA, Aducanumab, Treat, Alzheimer’s Disease

16. Novo Nordisk’s Fiasp (insulin aspart injection) Receives the FDA’s Approval for use in Insulin Infusion Pumps to Treat Type 1 or Type 2 Diabetes

Published: Oct 22, 2019 | Tags: Novo Nordisk, Fiasp, insulin aspart injection, Insulin Infusion Pumps, Type 1 Diabetes, Type 2 Diabetes

17. Alvogen Signs an Exclusive Commercialization Agreement with Three Pharma Companies for PF708 (biosimilar, teriparatide)

Published: Oct 21, 2019 | Tags: Alvogen, Signs, Exclusive, Commercialization Agreement, Three, Pharma Companies, PF708, biosimilar, teriparatide

18. BMS Reports Result of Opdivo (nivolumab) + Yervoy (ipilimumab) + CT in P-III CheckMate-9LA Study as 1L Therapy for Lung Cancer

Published: Oct 22, 2019 | Tags: BMS, Reports, Result, Opdivo, nivolumab, Yervoy, ipilimumab, CT, P-III, CheckMate-9LA, 1L, Lung Cancer

19. Vertex’s Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) Receives the US FDA’s Approval to Treat the Underlying Cause of Cystic Fibrosis

Published: Oct 21, 2019 | Tags: Vertex, Trikafta, elexacaftor, tezacaftor, ivacaftor, Receives, US, FDA, Approval, Treat, Cystic Fibrosis

20. Pfizer and OPKO Reports Results of Somatrogon in P-III Study for Children with Growth Hormone Deficiency

Published: Oct 21, 2019 | Tags: Pfizer, OPKO, Reports, Results, Somatrogon, P-III, Study, Children, Growth Hormone Deficiency

21. Takeda Acquires Exclusive Worldwide License Rights for COUR’s CNP-101 to Treat Celiac Disease

Published: Oct 22, 2019 | Tags: Takeda, Acquires, Exclusive, Worldwide, License, COUR, CNP-101, Celiac Disease

22. Bayer to Terminate its JV Agreement with CRISPR Therapeutics

Published: Oct 21, 2019 | Tags: CRISPR, Casebia Therapeutics, Terminating, JV agreement, Bayer

23. Humana and Microsoft Collaborate to Reimagine Health Leveraging Azure Cloud and AI with Voice Technologies

Published: Oct 21, 2019 | Tags:  Humana, Microsoft, Collaborate, Reimagine, Health, Leveraging, Azure Cloud, AI, Voice Technologies

24. Janssen’s Stelara (ustekinumab) Receives the US FDA’s Approval for Moderately to Severely Active Ulcerative Colitis

Published: Oct 21, 2019 | Tags: Janssen, Stelara, ustekinumab, Receives, US, FDA, Approval, Moderately to Severely Active Ulcerative Colitis

25. Sartorius to Acquire Danaher’s Life Science Portfolio for $750M

Published: Oct 21, 2019 | Tags: Sartorius, Acquire, Danaher, Life Science Portfolio, $750M

26. AstraZeneca’s Farxiga (dapagliflozin) Receives the US FDA’s Approval for Reducing the Risk of Hospitalization for Heart Failure in Patients with Type-2 Diabetes

Published: Oct 21, 2019 | Tags: AstraZeneca, Farxiga, dapagliflozin, Receives, US, FDA, Approval, Reducing, Risk of Hospitalization, Heart Failure, Patients, Type-2 Diabetes

27. GSK to Divest its Rabipur and Encepur Vaccines to Bavarian Nordic for ~1B

Published: Oct 21, 2019 | Tags: GSK, Divest, Rabipur, Encepur, Vaccines, Bavarian Nordic, ~1B

28. Roche Reports Result of Tecentriq (atezolizumab) + Avastin (bevacizumab) in P-III IMbrave150 Study for Unresectable Hepatocellular Carcinoma

Published: Oct 21, 2019 | Tags: Roche, Reports, Result, Tecentriq, atezolizumab, Avastin, bevacizumab, P-III, IMbrave150, Study, Unresectable Hepatocellular Carcinoma

Tuba Khan

Tuba Khan is an Editor and Digital Marketing expert at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in Lifesciences industry. She covers Pharma, Medical devices, Diagnostics and Digital health segment. Tuba also has an experience of digital and social media marketing and can run the campaign independently. She is also certified as a Digital marketer and social media marketer. She can be contacted on tuba@pharmashots.com

Related post